GHCL Q2 FY27 Results: Standalone Net Profit ₹127 Crore on Total Income of ₹821 Crore
- Earnings
- Chemicals - Inorganic
Reviewed byKeshav SehgalBlacklitt Research
GHCL (NSE: GHCL) reported standalone total income of ₹821.26 crore and net profit of ₹127.42 crore for the quarter ended 30 Sep 2026, it said in a filing on 31 Oct 2026. Revenue from operations was ₹808.03 crore.
Key highlights
Standalone
The company on its own, without its subsidiaries
- Total income: ₹821.26 crore, up 11.1% YoY and 2.9% QoQ
- Net profit and EPS: ₹127.42 crore, up 18.7% YoY and down 33.4% QoQ; basic EPS ₹14.02
- Other income: ₹13.23 crore, down 25.2% YoY and 44.3% QoQ
- Exceptional items: ₹53.62 crore gain in the quarter ended 30 Jun 2026; none in the quarter under review
Summary
| Particulars | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| 821.26 | 738.97 | +11.1% | 798.01 | +2.9% | |
| Revenue from operations | 808.03 | 721.29 | +12.0% | 774.26 | +4.4% |
| Other income | 13.23 | 17.68 | -25.2% | 23.75 | -44.3% |
| 127.42 | 107.36 | +18.7% | 191.18 | -33.4% | |
| Profit before tax | 172.29 | 145.19 | +18.7% | 257.53 | -33.1% |
| Finance costs | 1.52 | 2.11 | -28.0% | 1.55 | -1.9% |
| Depreciation | 28.65 | 27.63 | +3.7% | 27.15 | +5.5% |
| Tax expense | 44.87 | 37.83 | +18.6% | 66.35 | -32.4% |
| Net profit margin | 15.52% | 14.53% | +0.99 pp | 23.96% | -8.44 pp |
| EPS, basic (₹) | 14.02 | 11.23 | +24.8% | 21.04 | -33.4% |
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Net profit grew faster than total income. Standalone net profit rose 18.7% YoY to ₹127.42 crore, while total income rose 11.1% to ₹821.26 crore. Revenue from operations, at ₹808.03 crore, rose 12.0%, and other income fell 25.2% to ₹13.23 crore.
Other income made up 1.6% of total income and 7.7% of profit before tax of ₹172.29 crore. Finance costs were ₹1.52 crore, or 0.2% of total income, down 28.0% from ₹2.11 crore a year earlier. Depreciation rose 3.7% to ₹28.65 crore.
Against the preceding quarter the picture differs. Net profit fell 33.4% from ₹191.18 crore, while total income rose 2.9%. The earlier quarter included an exceptional gain of ₹53.62 crore, and the statement shows none in the quarter under review. The filing does not give the reason for that gain.
Net profit margin widened to 15.52% from 14.53%.
The company has one reportable operating segment, chemical. Commercial production of vacuum salt began at the soda ash plant on 31 Aug 2026, with installed annual capacity of 1,70,000 metric tonnes. Commercial production of bromine began at the Kathivadar plant in Gujarat on 12 Oct 2026, with installed annual capacity of 2,800 metric tonnes, as reported in Blacklitt's earlier article on that start.
Net profit for the six months ended 30 Sep 2026 was ₹318.60 crore, against ₹252.14 crore a year earlier. The filing does not say how much revenue the two new units have contributed so far.
Inference
The board approved an additional capital budget of approximately ₹88.09 crore for FY 2026-27. The filing does not say what the budget will be spent on.
The statutory auditor, Deloitte Haskins & Sells LLP, issued an unmodified limited review report on the standalone results. The report notes that a trust included in the statement, which its auditor has not reviewed, is not material to the company.
The filing does not say what expected revenue or margin the new bromine and vacuum salt production will bring.
Filed with BSE on . Reference: Original filing (PDF)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.